HER2 Support Group Forums - View Single Post - Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

News · 12-13-2009, 11:02 PM

Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.

More...

12-13-2009, 11:02 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,109	Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839 Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer. More...